Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05BDY
|
|||
| Former ID |
DIB011329
|
|||
| Drug Name |
PXT-3003
|
|||
| Synonyms |
Pleodrug (Charcot Marie Tooth disease), Pharnext
Click to Show/Hide
|
|||
| Indication | Charcot marie tooth disease [ICD-11: 8C21.Z] | Phase 3 | [1] | |
| Company |
Pharnext SAS
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H27N3O2
|
|||
| Canonical SMILES |
CCOC(=O)C1=CC(=C(N=C1)NC2CCCCC2)NCC3=CC=CC=C3
|
|||
| InChI |
1S/C21H27N3O2/c1-2-26-21(25)17-13-19(22-14-16-9-5-3-6-10-16)20(23-15-17)24-18-11-7-4-8-12-18/h3,5-6,9-10,13,15,18,22H,2,4,7-8,11-12,14H2,1H3,(H,23,24)
|
|||
| InChIKey |
WRUIDZKNUAHKTR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1467047-91-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.